Cigarette smoking and p53 mutations in lung cancer and bladder cancer

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 3, 1996, Pages 553-556

  Husgafvel Pursiainen, Kirsti ^a   Kannio, Annamaria ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Bladder cancer; Cigarette smoking; Environmental cancer; Lung cancer; p53 mutation; p53 mutation profile

Indexed keywords

ADENINE; CIGARETTE SMOKE; CYTIDINE; GUANINE; PROTEIN P53; THYMINE;

ADULT; BLADDER CANCER; CIGARETTE SMOKING; CONFERENCE PAPER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MUTATION RATE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL;

EID: 0030004337     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s3553     Document Type: Conference Paper

References (28)

1. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428 (1991).
2. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in human hepatocellular carcinoma from southern Africa. Nature 350:429-430 (1991).
3. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128 (1991).
4. Vogelstein B, Kinzler KW. Carcinogens leave fingerprints. Nature 355:209-210 (1992).
5. IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 38: Tobacco smoking. Lyon:International Agency for Research on Cancer, 1986;244-270.
6. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans. Supplement 7: Overall Evaluations of Carcinogenicity: An Updating of IARC Monograph Volumes 1 to 42. Lyon: International Agency for Research on Cancer, 1987;106-116.
7. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA, Sidransky D. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 33:712-717 (1995).
8. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327 (1993).
9. Ridanpää M, Karjalainen A, Anttila S, Vainio H. Genetic alterations in p53 and K-ras in lung cancer in relation to histopathology of the tumor and smoking history of the patient. Int J Oncol 5:1109-1117 (1994).
10. Kannio A, Ridanpää M, Koskinen H, Partanen T, Anttila S, Collan Y, Hietanen E, Vainio H, Husgafvel-Pursiainen K. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking and occupational exposure to asbestos. Cancer Epidemiol Biomarkers Prev 5:33-39(1996).
11. Karjalainen A, Anttila S, Heikkilä L, Karhunen P, Vainio H. Asbestos exposure among Finnish lung cancer patients: occupational history and fiber concentration in lung tissue. Am J Ind Med 23:461-471 (1993).
12. Spruck CH III, Rideout WM III, Olumi AF, Ohneseit PF, Yang AS, Tsai YC, Nichols PW, Horn T, Hermann GG, Steven K, Ross RK, Yu MC, Jones PA. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res 53:1162-1166 (1993).
13. Williamson MP, Elder PA, Knowles MA. The spectrum of TP53 mutations in bladder carcinoma. Genes Chromosom Cancer 9:108-118 (1994).
14. Husgafvel-Pursiainen K, Hackman P, Ridanpää M, Anttila S, Karjalainen A, Partanen T, Taikina-aho O, Heikkilä L, Vainio H. K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int J Cancer 53:250-256 (1993).
15. Westra WH, Offerhaus GJA, Goodman SN, Slebos RJC, Polak M, Baas IO, Rodenhuis S, Hruban RH. Overexpression of the p53 tumor suppressor gene product in primary lung adenocar-cinomas is associated with cigarette smoking. Am J Surg Pathol 17:213-220 (1993).
16. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 309:901-911 (1994).
17. Puisieux A, Lim S, Groopman J, Ozturk M. Selective targeting of p53 gene mutational notspots in human cancers by etiologically denned carcinogens. Cancer Res 51:6185-6189 (1991).
18. Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T, Ueda R. p53 mutations in non-small cell lung cancer in Japan. Associations between mutations and smoking. Cancer Res 52:734-736 (1992).
19. Gosney JR, Gosney MA, Butt SA, Field JK. Over-expression of p53 protein and cigarette smoking in bronchial carcinoma. Int J Oncol 2:1071-1074 (1993).
20. Bongiorno PF, Whyte RI, Orringer MB, Beer DG, Lesser EJ, Moore JH, Mathisen DJ, McKneally MF. Alterations of K-ras, p53 and erbB-2/neu in human lung adenocarcinoma. J Thorac Cardiovasc Surg 107:590-595 (1994).
21. Takeshima Y, Seyama T, Bennet WP, Akiyama M, Tokuoka S, Inai K, Mabuchi K, Land CE, Harris CC. p53 mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet 342:1520-1521 (1993).
22. Zhang Z, Sarkis AS, Cordon-Cardo C, Dalbagni G, Melamed J, Aprikian A, Pollack D, Sheinfeld J, Herr HW, Fair WR, Reuter VE, Begg C. Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. Cancer Epidemiol Biomarkers Prev 3:19-24 (1994).
23. Uchida T, Wada C, Ishida H, Wang C, Egawa S, Yokoyama E, Kameya T, Koshiba K. p53 mutations and prognosis in bladder tumors. J Urol 153:1097-1104 (1995).
24. Hollstein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 253:49-53 (1991).
25. Esteve A, Sørlie T, Martel-Planche G, Hollstein M, Kusters I, LeWalter J, Vineis P, Montesano R. Screening for p53 gene mutations in archieved tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors. J Occup Environ Med 37:59-68 (1995).
26. Warren W, Biggs PJ, El-Baz M, Ghoneim MA, Stratton MR, Venitt S. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis 16(5):1181-1189 (1995).
27. Talaska G, Al-juburi AZSS, Kadlubar F. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci USA 88:5350-5354 (1991).
28. Alexandrov K, Rojas M, Geneste O, Castegnaro M, Camus AM, Petruzelli S, Giuntini C, Bartsch H. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and AHH activity. Cancer Res 52:6248-6253 (1992).